Literature DB >> 23306829

Membrane cholesterol affects stimulus-activity coupling in type 1, but not type 2, CCK receptors: use of cell lines with elevated cholesterol.

Kaleeckal G Harikumar1, Ross M Potter, Achyut Patil, Valerie Echeveste, Laurence J Miller.   

Abstract

The lipid microenvironment of membrane proteins can affect their structure, function, and regulation. We recently described differential effects of acute modification of membrane cholesterol on the function of type 1 and 2 cholecystokinin (CCK) receptors. We now explore the regulatory impact of chronic cholesterol modification on these receptors using novel receptor-bearing cell lines with elevated membrane cholesterol. Stable CCK1R and CCK2R expression was established in clonal lines of 25RA cells having gain-of-function in SCAP [sterol regulatory element binding protein (SREBP) cleavage-activating protein] and SRD15 cells having deficiencies in Insig-1 and Insig-2 enzymes affecting HMG CoA reductase and SREBP. Increased cholesterol in the plasma membrane of these cells was directly demonstrated, and receptor binding and signaling characteristics were shown to reflect predicted effects on receptor function. In both environments, both types of CCK receptors were internalized and recycled normally in response to agonist occupation. No differences in receptor distribution within the membrane were appreciated at the light microscopic level in these CHO-derived cell lines. Fluorescence anisotropy was studied for these receptors occupied by fluorescent agonist and antagonist, as well as when tagged with YFP. These studies demonstrated increased anisotropy of the agonist ligand occupying the active state of the CCK1R in a cholesterol-enriched environment, mimicking fluorescence of the uncoupled, inactive state of this receptor, while there was no effect of increasing cholesterol on fluorescence at the CCK2R. These cell lines should be quite useful for examining the functional characteristics of potential drugs that might be used in an abnormal lipid environment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306829      PMCID: PMC3587353          DOI: 10.1007/s11745-012-3744-4

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  35 in total

1.  Altered signal pathway in granulocytes from patients with hypercholesterolemia.

Authors:  G Paragh; E Kovács; I Seres; T Keresztes; Z Balogh; J Szabó; F Teichmann; G Fóris
Journal:  J Lipid Res       Date:  1999-09       Impact factor: 5.922

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 3.  Cholecystokinin and gastrin receptors.

Authors:  Marlène Dufresne; Catherine Seva; Daniel Fourmy
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

4.  Membrane cholesterol modulates galanin-GalR2 interaction.

Authors:  L Pang; M Graziano; S Wang
Journal:  Biochemistry       Date:  1999-09-14       Impact factor: 3.162

5.  Isolation of sterol-resistant Chinese hamster ovary cells with genetic deficiencies in both Insig-1 and Insig-2.

Authors:  Peter C W Lee; Navdar Sever; Russell A Debose-Boyd
Journal:  J Biol Chem       Date:  2005-05-02       Impact factor: 5.157

6.  Gallbladder relaxation in patients with pigment and cholesterol stones.

Authors:  Q Chen; J Amaral; S Oh; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

7.  Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.

Authors:  Kaleeckal G Harikumar; Jeremy Clain; Delia I Pinon; Maoqing Dong; Laurence J Miller
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

8.  Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Vishwajeet Puri; Raman Deep Singh; Kentaro Hanada; Richard E Pagano; Laurence J Miller
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

9.  Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; Keiko Hosohata; Delia I Pinon; Laurence J Miller
Journal:  J Biol Chem       Date:  2005-11-30       Impact factor: 5.157

10.  Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern.

Authors:  H Li; V Papadopoulos
Journal:  Endocrinology       Date:  1998-12       Impact factor: 4.736

View more
  14 in total

Review 1.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

2.  Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol.

Authors:  Aditya J Desai; Maoqing Dong; Laurence J Miller
Journal:  Clin Nutr       Date:  2016-03-15       Impact factor: 7.324

3.  Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function.

Authors:  Aditya J Desai; Maoqing Dong; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

4.  Emerging Diversity in Lipid-Protein Interactions.

Authors:  Valentina Corradi; Besian I Sejdiu; Haydee Mesa-Galloso; Haleh Abdizadeh; Sergei Yu Noskov; Siewert J Marrink; D Peter Tieleman
Journal:  Chem Rev       Date:  2019-02-13       Impact factor: 60.622

Review 5.  Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.

Authors:  A J Desai; M Dong; K G Harikumar; L J Miller
Journal:  Int J Obes Suppl       Date:  2016-11-16

6.  Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.

Authors:  Aditya J Desai; Polo C H Lam; Andrew Orry; Ruben Abagyan; Arthur Christopoulos; Patrick M Sexton; Laurence J Miller
Journal:  J Med Chem       Date:  2015-12-10       Impact factor: 7.446

7.  Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Erin E Cawston; Polo C H Lam; Achyut Patil; Andrew Orry; Brad R Henke; Ruben Abagyan; Arthur Christopoulos; Patrick M Sexton; Laurence J Miller
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

8.  A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.

Authors:  Aditya J Desai; Kaleeckal G Harikumar; Laurence J Miller
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

9.  Expression of cholecystokinin receptors in colon cancer and the clinical correlation in Taiwan.

Authors:  Bee-Piao Huang; Chun-Hsiang Lin; Yi-Ching Chen; Shao-Hsuan Kao
Journal:  Tumour Biol       Date:  2015-10-27

Review 10.  Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics.

Authors:  Laurence J Miller; Kaleeckal G Harikumar; Denise Wootten; Patrick M Sexton
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.